Global Anti-depressant Drugs Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 2.1% - ResearchAndMarkets.com

DUBLIN--()--The "Anti-depressant Drugs Market by Depressive Disorder and Product - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global anti-depressant drugs market was valued at $13,755 million in 2016, and is estimated to reach $15,983 million by 2023, registering a CAGR of 2.1% from 2017 to 2023.

Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.

According to WHO almost 350 million people worldwide were affected with depression in 2016. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps in the treatment of depression.

Key Benefits

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to type, method, technology, end user, and region.
  • In-depth analysis based on geography assists in understanding the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Companies Mentioned:

  • Alkermes Plc
  • Allergan Plc
  • Bristol Myers Squibb Company
  • Eli Lilly And Company
  • Glaxosmithkline Inc.
  • H. Lundbeck A/S
  • Merck Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Inc.

Key Topics Covered:

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Anti-Depressant Drugs Market By Depressive Disorder

Chapter 5: Anti-Depressant Drugs Market By Product Type

Chapter 6: Anti-Depressant Drugs Market By Geography

Chapter 7: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/hkj36v/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs